The close collaboration with Peter MacCallum Cancer Centre in
Melbourne is hugely significant. We know that they are working closely but reinforcing this relationship publicly is perhaps the most important part of this announcement.
It provides a significant credibility factor to Prima that should not be lost on potential investors.
Prima is not working on commercial isolation, it has a strong working relationship with an institution in the mainstream of clinical practice. That's huge.
_______
In Europe, and only occasionally in touch: in the state of the markets that's probably a good thing!
The close collaboration with Peter MacCallum Cancer Centre...
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
-0.020(6.45%) |
Mkt cap ! $421.2M | |||
| Open | High | Low | Value | Volume |
| 31.5¢ | 31.5¢ | 28.0¢ | $2.100M | 7.109M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 233293 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 36945 | 2 |
View Market Depth
| Last trade - 16.10pm 02/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |